PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9338077-3	1998	First, the activity of ara-C depends on conversion to its lethal triphosphate derivative, ara-CTP, a process that is influenced by multiple factors, including nucleoside transport, phosphorylation, deamination, and levels of competing metabolites, particularly dCTP.	triphosphoric acid	65-77	solute carrier family 25 member 1	Homo sapiens	94-97	
3567973-2	1987	Studies were performed to determine if m-AMSA affected the pharmacokinetics of the active triphosphate ara-CTP in HL-60 and K562 cells in culture.	triphosphoric acid	90-102	solute carrier family 25 member 1	Homo sapiens	107-110	
8547650-1	1996	The effectiveness of arabinosylcytosine (ara-C) for the treatment of acute myelogenous leukemia (AML) depends on the formation of its active metabolite, the triphosphate of ara-C (ara-CTP).	triphosphoric acid	157-169	solute carrier family 25 member 1	Homo sapiens	184-187	
8174200-1	1994	Previous studies have demonstrated that treatment with fludarabine 4 h prior to arabinosylcytosine (ara-C) potentiates the accumulation of the active triphosphate of ara-C (ara-CTP) in leukemic lymphocytes.	triphosphoric acid	150-162	solute carrier family 25 member 1	Homo sapiens	177-180